Administration

爱荷华大学/梅奥诊所淋巴瘤孢子(UI/MC孢子)的总体目标 管理核心是刺激对淋巴瘤的研究，并加快将发现转化为 预防、检测和治疗淋巴瘤的新的和更好的方法。行政核心有 在最初的供资期间，它很好地充当了UI/MC孢子的组织中心。在下一次拨款期间 在此期间，它将继续提供一个旨在有效协调下列活动的组织结构 研究项目、科学核心和发展计划(发展研究计划、 职业发展计划)。它还将有助于加强两国之间的沟通 爱荷华州和梅奥的调查人员。行政核心将负责协调 孢子委员会，包括执行委员会和外部咨询委员会。乔治博士 韦纳将担任行政核心主任，托马斯·维齐格博士将担任联席主任。韦纳和 在最初的资助期，Witzig作为一个团队运作良好，并将继续合作 提供实验室和临床淋巴瘤研究方面的专业知识。他们有广泛的行政管理 具有丰富的经验，完全有资格为UI/MC孢子提供领导和指导。这个 行政核心将通过以下方式支持孢子活动：(1)提供领导、组织支持和 UI/MC孢子调查员的财务管理；(2)协调每月的电视会议和 UI/MC孢子研究人员的季度会议，以及正在进行的孢子研究的科学审查 项目和核心以及外部顾问的访问；(3)为遴选和 支持孢子指南中概述的最佳和最有前景的项目；(4)提供信息 通过专业和公共手段向科学界转移；(5)为 建立和培育合作，以促进和扩大淋巴瘤研究；(6)确保投入 患者权益倡导者和(7)促进实习生发展。

The overall goal of the University of Iowa/Mayo Clinic Lymphoma SPORE (UI/MC SPORE) Administration Core is to stimulate research in lymphoma and to expedite the translation of discoveries into new and better methods of prevention, detection, and treatment of lymphoma. The Administration Core has served well as the organizational hub of UI/MC SPORE during the initial funding period. During the next grant period it will continue to provide an organizational structure designed to efficiently coordinate the activities of the research projects, scientific cores, and developmental programs (Developmental Research Program, Career Development Program) of the UI/MC SPORE. It will also serve to enhance communication between investigators at Iowa and Mayo. The Administration Core will be responsible for coordinating the function of the SPORE committees including the Executive Committee and the External Advisory Committee. Dr. George Weiner will serve as Director of the Administration Core, and Dr. Thomas Witzig as Co-Director. Weiner and Witzig functioned well as a team during the initial funding period, and will continue to work collaboratively to provide expertise in laboratory and clinical lymphoma research. They have extensive administrative experience and are well qualified to provide leadership and direction for the UI/MC SPORE. The Administration Core will support SPORE activities by: (1) providing leadership, organizational support, and financial management for UI/MC SPORE investigators; (2) coordinating monthly videoconferences and quarterly meetings of UI/MC SPORE investigators, and the ongoing scientific review of SPORE research projects and cores, and the visits of the external advisors; (3) providing the infrastructure for the selection and support of the best and most promising projects as outlined in SPORE guidelines; (4) providing for information transfer to the scientific community via professional and public means; (5) providing the structure for the establishment and nurture of collaborations to facilitate and expand lymphoma research; (6) assuring input from patient advocates and (7) fostering trainee development.